[Clinico-statistical study of medical treatment of hyperazotemic syndromes of prevalently dysmetabolic origin].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000150:complications; D001660:Biliary Tract Diseases / Q000150:complications; D048909:Diabetes Complications; D004338:Drug Combinations; D005260:Female; D005767:Gastrointestinal Diseases / Q000150:complications; D005978:Glutathione / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D008297:Male; D008659:Metabolic Diseases / Q000150:complications*; D008875:Middle Aged; D014511:Uremia / Q000188:drug therapy* / Q000209:etiology; D014532:Uridine Diphosphate Glucose / Q000627:therapeutic use*; D014539:Uridine Diphosphate Sugars / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use*
D004338:Drug Combinations; D014539:Uridine Diphosphate Sugars; D005978:Glutathione; D014805:Vitamin B 12; D014532:Uridine Diphosphate Glucose
Indagine clinico-statistica su un trattamento medicamentoso di sindromi iperazotemiche di prevalente origine dismetabolica